EichorEICHOR
Study identifier: NCT07300969 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: RecruitingTarian-1

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Condition: Major Depressive Disorder (MDD)  ·  Sponsor: Draig Therapeutics Ltd

PhasePhase 2
Planned participants300
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNoCheck eligibility criteria ↓
Where40 locations · 5 countries

Interested? Contact the study team ↓

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.

This description comes directly from the study's public registry record.

Talk to the study team

Chief Medical Officer  ·  +44(0)2920028450  ·  info@draigtherapeutics.com

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * The participant is able to read, understand and communicate in the local language used at the study site, and is willing to provide written informed consent * Male or female (assigned at birth, inclusive of all gender identities) participant must be 18 to 75 years of age, inclusive at the time of signing the informed consent. * Has recurrent depression (defined as at least one prior episode excluding the current one), as diagnosed by DSM 5-TR (Diagnostic and Statistical Manual of Mental Disorders, 2022). Exclusion Criteria: * Pregnant or breastfeeding or plans to become pregnant during the study. * Unstable medical condition or unstable chronic disease. * Significant neurological abnormality. * History of moderate or severe alcohol or drug use disorder as per DSM-5-TR in the 6 months prior to Screening. * History of seizure. * In the investigator's opinion, the participant is not capable of adhering to the protocol requirements.

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (40)

Draig Clinical SiteBentonville, Arkansas, United StatesRecruiting
Draig Clinical SiteLittle Rock, Arkansas, United StatesRecruiting
Draig Clinical SiteOceanside, California, United StatesRecruiting
Draig Clinical SiteSan Diego, California, United StatesRecruiting
Draig Clinical SiteTorrance, California, United StatesRecruiting
Draig Clinical SiteMiami, Florida, United StatesRecruiting
Draig Clinical SiteNew Port Richey, Florida, United StatesRecruiting
Draig Clinical SiteOrlando, Florida, United StatesRecruiting
Draig Clinical SiteAtlanta, Georgia, United StatesRecruiting
Draig Clinical SiteDecatur, Georgia, United StatesRecruiting
Draig Clinical SiteGaithersburg, Maryland, United StatesRecruiting
Draig Clinical SiteWatertown, Massachusetts, United StatesRecruiting

+ 28 more locations — full list on the registry record.

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

BentonvilleLittle RockOceansideSan Diego

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →